Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | 311,785 | reported | 18 Jan 2021 | tx 11+768,157−43,872 |
| OnKure Therapeutics, Inc. | 16,000 | reported | 23 Mar 2026 | tx 11+223,045−4,331 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | SALE | OnKure Therapeutics, Inc. | 301 | 4.16 USD | |
| 22 Dec 2025 | SALE | OnKure Therapeutics, Inc. | 302 | 2.97 USD | |
| 22 Sept 2025 | SALE | OnKure Therapeutics, Inc. | 303 | 2.62 USD | |
| 23 Jun 2025 | SALE | OnKure Therapeutics, Inc. | 303 | 2.38 USD | |
| 04 Apr 2025 | SALE | OnKure Therapeutics, Inc. | 1,278 | 3.33 USD | |
| 07 Apr 2025 | SALE | OnKure Therapeutics, Inc. | 1,844 | 2.67 USD | |
| 27 Jan 2025 | GRANT_AWARD | OnKure Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 16,331 | — | |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 5,781 | — | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 130,611 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 5,322 | — | deriv |
| 18 Jan 2021 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 311,785 | 0.00 USD | deriv |
| 13 Mar 2020 | EXERCISE | Viridian Therapeutics, Inc.\DE | 11,249 | 0.57 USD | |
| 13 Mar 2020 | EXERCISE | Viridian Therapeutics, Inc.\DE | 11,249 | 0.00 USD | deriv |
| 12 Feb 2020 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 185,000 | 0.00 USD | deriv |
| 23 Aug 2019 | EXERCISE | Viridian Therapeutics, Inc.\DE | 3,093 | 0.57 USD | |
| 23 Aug 2019 | EXERCISE | Viridian Therapeutics, Inc.\DE | 3,093 | 0.00 USD | deriv |
| 06 Feb 2019 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 75,000 | 0.00 USD | deriv |
| 07 Aug 2018 | EXERCISE | Viridian Therapeutics, Inc.\DE | 29,530 | 0.57 USD | |
| 07 Aug 2018 | EXERCISE | Viridian Therapeutics, Inc.\DE | 29,530 | 0.00 USD | deriv |
| 31 Jan 2018 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 75,000 | 0.00 USD | deriv |
| 16 Feb 2017 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 77,500 | 0.00 USD | deriv |